- Home
- SURG vs VYNE Comparison
SURG vs VYNE Comparison
Compare SURG & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- VYNE
- Stock Information
- Founded
- SURG 2006
- VYNE 2003
- Country
- SURG United States
- VYNE United States
- Employees
- SURG N/A
- VYNE N/A
- Industry
- SURG Advertising
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- VYNE Health Care
- Exchange
- SURG Nasdaq
- VYNE Nasdaq
- Market Cap
- SURG 31.3M
- VYNE 35.7M
- IPO Year
- SURG N/A
- VYNE 2018
- Fundamental
- Price
- SURG $1.37
- VYNE $2.74
- Analyst Decision
- SURG Buy
- VYNE Strong Buy
- Analyst Count
- SURG 2
- VYNE 2
- Target Price
- SURG $8.50
- VYNE $6.88
- AVG Volume (30 Days)
- SURG 118.6K
- VYNE 86.1K
- Earning Date
- SURG 03-11-2025
- VYNE 03-07-2025
- Dividend Yield
- SURG N/A
- VYNE N/A
- EPS Growth
- SURG N/A
- VYNE N/A
- EPS
- SURG N/A
- VYNE N/A
- Revenue
- SURG $83,602,653.00
- VYNE $493,000.00
- Revenue This Year
- SURG N/A
- VYNE $28.30
- Revenue Next Year
- SURG $59.69
- VYNE N/A
- P/E Ratio
- SURG N/A
- VYNE N/A
- Revenue Growth
- SURG N/A
- VYNE 39.27
- 52 Week Low
- SURG $1.33
- VYNE $1.57
- 52 Week High
- SURG $8.05
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- SURG 35.64
- VYNE 56.12
- Support Level
- SURG $1.37
- VYNE $2.39
- Resistance Level
- SURG $1.55
- VYNE $2.65
- Average True Range (ATR)
- SURG 0.08
- VYNE 0.20
- MACD
- SURG 0.00
- VYNE 0.05
- Stochastic Oscillator
- SURG 18.18
- VYNE 71.01
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.